CLVS - Clovis Oncology Inc
Previous close
0.0812
0 0%
Share volume: 0
Last Updated: Tue 20 Dec 2022 06:00:00 AM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.08
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | |
| Report Date | 2022-05-05 | 2022-08-08 | 2022-11-09 | |
| Assets | ||||
| Total Assets | 451.529 M | 392.856 M | 346.775 M | |
| Current Assets | 185.535 M | 142.284 M | 102.209 M | |
| Inventories | 14.504 M | 13.232 M | 11.419 M | |
| Other Current Assets | 15.975 M | 13.074 M | 11.549 M | |
| Short Term Investments | 15.975 M | 13.074 M | 11.549 M | |
| Total Receivables | 32.815 M | 21.399 M | 20.921 M | |
| Current Cash | 122.241 M | 94.579 M | 58.320 M | |
| Total Non-current Assets | 265.994 M | 250.572 M | 244.566 M | |
| Property Plant Equipment | 5.987 M | 5.386 M | 4.851 M | |
| Other Assets | 119.229 M | 106.665 M | 103.634 M | |
| Intangible Assets | 59.029 M | 57.686 M | 56.343 M | |
| Goodwill | 63.074 M | 63.074 M | 63.074 M | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 451.529 M | 392.856 M | 346.775 M | |
| Total liabilities | 754.835 M | 760.551 M | 764.661 M | |
| Total current liabilities | 121.832 M | 121.272 M | 747.870 M | |
| Accounts Payable | 22.332 M | 24.228 M | 18.123 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 17.000 M | 25.500 M | 660.375 M | |
| Long term debt | 613.999 M | 621.384 M | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -303.306 M | -367.695 M | -417.886 M | |
| Common stock | 138.205 M | 144.036 M | 144.625 M | |
| Retained earnings | -2.937 B | -3.009 B | -3.065 B |